Literature DB >> 11259692

Management of acute physiological parameters after stroke.

A Bhalla1, C D Wolfe, A G Rudd.   

Abstract

Considerable effort has been directed towards acute stroke research with numerous drug therapies being tried and tested. As yet there is still no routine treatment that is unequivocally effective in acute stroke. The development of stroke units has been a major breakthrough in reducing disability through co-ordinated rehabilitation, and new interest is being focussed towards limiting acute neurological deterioration through acute stroke units. Monitoring and attempting to stabilize acute physiological parameters within normal limits such as blood pressure, temperature, hydration status, glucose levels and oxygen saturations, has become standard practice for some acute stroke units. Strategies to correct hypertension, hypotension, dehydration, hyperglycaemia, pyrexia and hypoxia may potentially reduce neuronal damage in the acute phase of stroke and subsequently improve functional outcome and survival. Whether we require large prospective randomized controlled trials to test whether these specific interventions are to be used in mainstay practice is unclear.

Entities:  

Mesh:

Year:  2001        PMID: 11259692     DOI: 10.1093/qjmed/94.3.167

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  3 in total

1.  Plasma osmolality in acute spontanious intra-cerebral hemorrhage: Does it influence hematoma volume and clinical outcome?

Authors:  Chiranjib Nag; Kamalesh Das; Mrinalkanti Ghosh; M R Khandakar
Journal:  J Res Med Sci       Date:  2012-06       Impact factor: 1.852

2.  Erythropoietin Pretreatment Effect on Blood Glucose and Its Relationship With Inflammatory Factors After Brain Ischemic-Reperfusion Injury in Rats.

Authors:  Raheleh Gholamzadeh; Mehdi Eskandari; Mohammad Reza Bigdeli; Hossein Mostafavi
Journal:  Basic Clin Neurosci       Date:  2018-09-01

3.  Aggressive glucose control for acute ischemic stroke patients by insulin infusion.

Authors:  Nayoung Kim; Yunsook Jhang; Jong-Moo Park; Byung-Kun Kim; Ohyun Kwon; Jungju Lee; Ji-Sung Lee; Ja-Seong Koo
Journal:  J Clin Neurol       Date:  2009-12-31       Impact factor: 3.077

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.